cff-version: 1.2.0
abstract: "<p>Objective: to explain anti-HBc is a new predictor of peginterferon
treatment response. </p><p> </p><p>Type of research: clinical trial.</p><p> </p><p>Method of data collection: Serum samples were collected every 12
weeks, and were tested.</p><p> </p><p>











</p><p>Type of data: clinical data.</p>"
authors:
  - family-names: Jia
    given-names: Wei
title: "A baseline model including quantitative anti-HBc to predict response of peginterferon in HBeAg-positive patients."
keywords:
version: 1
identifiers:
  - type: doi
    value: 10.4121/14646039.v1
license: CC0
date-released: 2021-05-26